<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DICLOXACILLIN SODIUMÂ - dicloxacillin sodiumÂ capsuleÂ </strong><br>PD-Rx Pharmaceuticals, Inc.<br></p></div>
<h1>DICLOXACILLIN SODIUM CAPSULES USP<br>3123<br>3125<br>Rx only</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_dbc7142e-dbb6-42b6-8384-60bdb44fce7c"></a><a name="section-1"></a><p></p>
<p class="First">To reduce the development of drug resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules USP and other antibacterial drugs, dicloxacillin sodium capsules USP should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_ef9ea3f3-f02a-4406-8e46-15c1ab833105"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Dicloxacillin sodium is a semisynthetic antibiotic substance which resists destruction by the enzyme penicillinase(beta - lactamase). It is monosodium (2<span class="Italics">S</span>,5<span class="Italics">R</span>,6<span class="Italics">R</span>)-6-[3-(2,6-dichlorophenyl)- 5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0]heptane-2-carboxylate monohydrate.</p>
<p>Dicloxacillin is administered orally via capsule form or powder for reconstitution. Structurally, dicloxacillin sodium may be represented as follows:</p>
<div class="Figure">
<img alt="Structural formula for dicloxacillin sodium" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=24e821aa-85b8-4f5a-aa13-83ff132952ca&amp;name=f5cf34cb-e32d-418f-9eb9-593c73e653d9-01.jpg"><p class="MultiMediaCaption"></p>
</div>
<p>C<span class="Sub">19</span>H<span class="Sub">16</span>Cl<span class="Sub">2</span>N<span class="Sub">3</span>NaO<span class="Sub">5</span> SÂ·H<span class="Sub">2</span>O        MW 510.32</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_62cac392-384b-4119-907e-32d160b8eac7"></a><a name="section-2.1"></a><p></p>
<h2>Inactive Ingredients</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_338a114a-1f7d-482f-a197-3909fb6ba11c"></a><a name="section-2.1.1"></a><p></p>
<h3>Capsules</h3>
<p class="First">Magnesium Stearate.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_8093b1af-59bb-4962-b03f-f8eee61d20e6"></a><a name="section-2.1.2"></a><p></p>
<h3>Capsule Shell and Print Constituents</h3>
<p class="First">D&amp;C Yellow #10 Aluminum Lake, FD&amp;C Blue #1 Aluminum Lake, FD&amp;C Blue #1, FD&amp;C Blue #2 Aluminum Lake, FD&amp;C Red #40 Aluminum Lake, D&amp;C Yellow #10, Gelatin, Shellac, Sodium Lauryl Sulfate, Sorbitan Monlaurate, Black Iron Oxide, Titanium Dioxide, Propylene Glycol.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_c1696519-7fd2-46f0-9275-e1170d2b3eca"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_bebfd2fd-9a0c-48ee-92a1-ae928f8acd65"></a><a name="section-3.1"></a><p></p>
<h2>Microbiology</h2>
<p class="First">Dicloxacillin exerts a bactericidal action against penicillin-susceptible microorganisms during the state of active multiplication. All penicillins inhibit the biosynthesis of the bacterial cell wall.</p>
<p>The drugs in this class are highly resistant to inactivation by staphylococcal penicillinase and are active against penicillinase-producing and nonpenicillinase-producing <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics">Staphylococcus aureus. </span>The penicillinase- resistant penicillins are active <span class="Italics">in vitro </span>against a variety of other bacteria.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_4f7778d3-664f-4ed6-9c82-e35542355484"></a><a name="section-3.2"></a><p></p>
<h2>Susceptibility Plate Testing</h2>
<p class="First">Quantitative methods of susceptibility testing that require measurements of zone diameters or minimal inhibitory concentrations (MICs) give the most precise estimates of antibiotic susceptibility. One such procedure has been recommended for use with discs to test susceptibility to this class of drugs. Interpretations correlate diameters on the disc test with MIC values.</p>
<p>A penicillinase-resistant class disc may be used to determine microbial susceptibility to dicloxacillin.</p>
<p><span class="Bold">TABLE I</span> shows the interpretation of test results for penicillinase-resistant penicillins using the FDA Standard Disc Test Method (formerly Bauer-Kirby-Sherris-Turck method) of disc bacteriological susceptibility testing for staphylococci with a disc containing 5 micrograms of methicillin sodium.</p>
<p>With this procedure, a report from a laboratory of â€œsusceptibleâ€? indicates that the infecting organism is likely to respond to therapy. A report of â€œresistantâ€? indicates that the infecting organism is not likely to respond to therapy. A report of â€œintermediateâ€? susceptibility suggests that the organism might be susceptible if high doses of the antibiotic are used, or if the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> is confined to tissues and fluids (e.g., urine) in which high antibiotic levels are attained.</p>
<p>In general, all staphylococci should be tested against the penicillin G disc and against the methicillin disc. Routine methods of antibiotic susceptibility testing may fail to detect <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of organisms resistant to the penicillinase-resistant penicillins. For this reason, the use of large inocula and 48 hour incubation periods may be necessary to obtain accurate susceptibility studies with these antibiotics. Bacterial <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> which are resistant to one of the penicillinase-resistant penicillins should be considered resistant to all of the drugs in the class.</p>
<a name="id_89fba678-fcc5-4950-b678-a10ae27f885e"></a><table border="1" width="299">
<caption><span>Table I STANDARDIZED DISC TEST METHOD OF BACTERIOLOGICAL SUSCEPTIBILITY TESTING USING A CLASS DISC CONTAINING 5 MICROGRAMS OF METHICILLIN SODIUM</span></caption>
<col width="34.8%">
<col width="41.1%">
<col width="24.1%">
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle">Diameter of Zone</td>
<td class="Botrule Rrule" align="center" valign="middle">Diameter of Zone</td>
<td class="Botrule Rrule" align="center" valign="middle">Diameter of Zone</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="middle">Indicating â€œSusceptibleâ€?</td>
<td class="Botrule Rrule" align="center" valign="middle">Indicating</td>
<td class="Botrule Rrule" align="center" valign="middle">Indicating â€œResistantâ€?</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="middle">at least</td>
<td class="Botrule Rrule" align="center" valign="middle">â€œIntermediateâ€?</td>
<td class="Botrule Rrule" align="center" valign="middle">Less than</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="center" valign="middle">14 mm</td>
<td class="Rrule" align="center" valign="middle">10 â€“ 13 mm</td>
<td class="Botrule Rrule" align="center" valign="middle">10 mm</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_c5fb1725-a909-4f0a-bbb0-c496ce95aed2"></a><a name="section-3.3"></a><p></p>
<h2>Pharmacokinetics</h2>
<p class="First">Methicillin sodium is readily destroyed by gastric acidity and must be administered by intramuscular or intravenous injection. The isoxazolyl penicillins (cloxacillin, dicloxacillin and oxacillin) and nafcillin are more acid-resistant and may be administered orally.</p>
<p>Absorption of the isoxazolyl penicillins after oral administration is rapid but incomplete; peak blood levels are achieved in 1-1.5 hours. In one study, after ingestion of a single 500 mg oral dose, peak serum concentrations range from 5-7 micrograms/milliliter for oxacillin, from 7.5-14.4 mcg/mL for cloxacillin and from 10-17 mcg/mL for dicloxacillin.</p>
<p>Oral absorption of cloxacillin, dicloxacillin, oxacillin and nafcillin is delayed when the drugs are administered after meals.</p>
<p>Once absorbed, the penicillinase-resistant penicillins bind to serum protein, mainly albumin. The degree of protein binding reported varies with the method of study and the investigator (see <span class="Bold">TABLE II</span>).</p>
<a name="id_f85014fb-dbb9-4cf1-984c-14e534e46308"></a><table border="1" width="202">
<caption><span>TABLE II PENICILLINASE-RESISTANT PENICILLINS PERCENT PROTEIN BINDING Â± SD</span></caption>
<col width="39.1%">
<col width="60.9%">
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="left" valign="middle">Methicillin</td>
<td class="Botrule Rrule" align="left" valign="middle">37.3 Â± 7.9</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="middle">Nafcillin</td>
<td class="Botrule Rrule" align="left" valign="middle">89.9 Â± 1.5</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="middle">Oxacillin</td>
<td class="Botrule Rrule" align="left" valign="middle">94.2 Â± 2.1</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="middle">Cloxacillin</td>
<td class="Botrule Rrule" align="left" valign="middle">95.2 Â± 0.5</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="middle">Dicloxacillin</td>
<td class="Botrule Rrule" align="left" valign="middle">97.9 Â± 0.6</td>
</tr>
</tbody>
</table>
<p>The penicillinase-resistant penicillins vary in the extent to which they are distributed in the body fluids. With normal doses, insignificant concentrations are found in the cerebrospinal fluid and aqueous humor. All the drugs in this class are found in therapeutic concentrations in the pleural, bile and amniotic fluids.</p>
<p>The penicillinase-resistant penicillins are rapidly excreted, primarily as unchanged drug in the urine by glomerular filtration and active tubular secretion. The elimination half-life for dicloxacillin is about 0.7 hour. Nonrenal elimination includes hepatic inactivation and excretion in bile.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_04fb0f42-9cd2-4e18-9d57-1a77e5e70058"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules USP and other antibacterial drugs, dicloxacillin sodium capsules USP should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</p>
<p>Dicloxacillin is indicated in the treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. Cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see <span class="Bold">CLINICAL PHARMACOLOGY â€“ Susceptibility Plate Testing</span>)<span class="Bold">.</span></p>
<p>Dicloxacillin may be used to initiate therapy in suspected cases of resistant <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infections</span> prior to the availability of laboratory test results. The penicillinase-resistant penicillins should not be used in <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by organisms susceptible to penicillin G. If the susceptibility tests indicate that the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> is due to an organism other than a resistant staphylococcus, therapy should not be continued with a penicillinase-resistant penicillin.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_0601ed28-2e7b-4b07-9714-a0e3a835781e"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">A history of a <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> (anaphylactic) reaction to any penicillin is a contraindication.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_09a16d56-db14-42c2-ad2f-4c7e7e54fe1d"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Serious and occasionally fatal <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> (<span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span> with collapse) reactions have occurred in patients receiving penicillin. The incidence of <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span> in all penicillin-treated patients is between 0.015% and 0.04%. <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">Anaphylactic shock</span> resulting in <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> has occurred in approximately 0.002% of the patients treated. Although <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span> is more frequent following a parenteral administration, it has occurred in patients receiving oral penicillins.</p>
<p>When penicillin therapy is indicated, it should be initiated only after a comprehensive patient drug and <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> history has been obtained. If an <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span> occurs, the drug should be discontinued and the patient should receive supportive treatment, e.g., artificial maintenance of ventilation, pressor amines, antihistamines and corticosteroids. Individuals with a history of penicillin <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> may also experience <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> when treated with a cephalosporin.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_e4061238-c4cf-4eef-af00-5b65fab79282"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_1168c171-ff64-4918-83df-7251b0a97a4e"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Prescribing dicloxacillin sodium capsules USP in the absence of a proven or strongly suspected <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span> or a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.</p>
<p>Dicloxacillin should generally not be administered to patients with a history of sensitivity to any penicillin.</p>
<p>Penicillin should be used with caution in individuals with histories of significant allergies and/or <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>. Whenever <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> occur, penicillin should be withdrawn unless, in the opinion of the physician, the condition being treated is life-threatening and amenable only to penicillin therapy.</p>
<p>The oral route of administration should not be relied upon in patients with severe illness, or with <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="195301" conceptname="Acute dilatation of stomach">gastric dilatation</span>, <span class="product-label-link" type="condition" conceptid="318186" conceptname="Achalasia of esophagus">cardiospasm</span> or <span class="product-label-link" type="condition" conceptid="4010029" conceptname="Increased intestinal motility">intestinal hypermotility</span>. Occasionally, patients will not absorb therapeutic amounts of orally administered penicillin.</p>
<p>The use of antibiotics may result in overgrowth of nonsusceptible organisms. If new <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to bacteria or fungi occur, the drug should be discontinued and appropriate measures taken.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_24d09386-ecb3-4127-ac10-1923fc8723fb"></a><a name="section-7.2"></a><p></p>
<h2>Information for the Patient</h2>
<p class="First">Patients should be counselled that antibacterial drugs including dicloxacillin sodium capsules USP should only be used to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>. They do not treat <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> (e.g., the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>). When dicloxacillin sodium capsules USP are prescribed to treat a <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span>, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by dicloxacillin sodium capsules USP or other antibacterial drugs in the future.</p>
<p>Patients receiving penicillins should be given the following information and instructions by the physician:</p>
<ol>
<li>Patients should be told that penicillin is an antibacterial agent which will work with the bodyâ€™s natural defenses to control certain types of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>. They should be told that the drug should not be taken if they have had an <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span> to any form of penicillin previously, and to inform the physician of any allergies or previous <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> to any drugs they may have had (see <span class="Bold">WARNINGS</span>).</li>
<li>Patients who have previously experienced an <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reaction</span> to penicillin should be instructed to wear a medical identification tag or bracelet.</li>
<li>Because most antibacterial drugs taken by mouth are best absorbed on an empty stomach, patients should be directed, unless circumstances warrant otherwise, to take penicillin one hour before meals or two hours after eating (see <span class="Bold">CLINICAL PHARMACOLOGY</span> - <span class="Bold">Pharmacokinetics</span>).</li>
<li>Patients should be told to take the entire course of therapy prescribed, even if <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and other symptoms have stopped (see <span class="Bold">PRECAUTIONS</span> - <span class="Bold">General</span>).</li>
<li>If any of the following reactions occur, stop taking your prescription and notify the physician: <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">shortness of breath</span>, <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">wheezing</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="138455" conceptname="Stomatitis">mouth irritation</span>, black tongue, <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="4154927" conceptname="Joint swelling">swollen joints</span> or any unusual <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> or <span class="product-label-link" type="condition" conceptid="441737" conceptname="Contusion">bruising</span> (see <span class="Bold">ADVERSE REACTIONS</span>).</li>
<li>Do not take any additional medications without physician approval, including nonprescription drugs such as antacids, laxatives or vitamins.</li>
<li>Discard any liquid forms of penicillin after seven days if stored at room temperature or after 14 days if refrigerated.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="i4i_lab_tests_id_af1ca5a0-a84c-42c6-bbc5-af690edfb1ee"></a><a name="section-7.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Bacteriologic studies to determine the causative organisms and their susceptibility to the penicillinase-resistant penicillins should be performed (see <span class="Bold">CLINICAL PHARMACOLOGY - Microbiology</span>). In the treatment of suspected <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infections</span>, therapy should be changed to another active agent if culture tests fail to demonstrate the presence of staphylococci.</p>
<p>Periodic assessment of organ system function, including renal, hepatic and hematopoietic, should be made during prolonged therapy with the penicillinase-resistant penicillins.</p>
<p>Blood cultures, white blood cell and differential cell counts should be obtained prior to initiation of therapy and at least weekly during therapy with penicillinase-resistant penicillins.</p>
<p>Periodic urinalysis, blood urea nitrogen and creatinine determinations should be performed during therapy with the penicillinase-resistant penicillins and dosage alterations should be considered if these values become elevated. If any impairment of renal function is suspected or known to exist, a reduction in the total dosage should be considered and blood levels monitored to avoid possible neurotoxic reactions (see <span class="Bold">DOSAGE AND ADMINISTRATION</span>).</p>
<p><span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span> and SGPT values should be obtained periodically during therapy to monitor for possible liver function abnormalities.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_interactions_id_3e36af69-0a6a-49bb-8a1e-493597408908"></a><a name="section-7.4"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_0e103ed2-ff65-42eb-9104-357c828e5529"></a><a name="section-7.5"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No long-term animal studies have been conducted with these drugs.</p>
<p>Studies on reproduction (nafcillin) in rats and rabbits reveal no fetal or maternal abnormalities before conception and continuously through weaning (one generation).</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_58166b27-b18a-4074-99f3-53be6704b8f9"></a><a name="section-7.6"></a><p></p>
<h2>Pregnancy Category B</h2>
<p class="First">Reproduction studies performed in the mouse, rat and rabbit have revealed no evidence of impaired fertility or harm to the fetus due to the penicillinase-resistant penicillins. Human experience with the penicillins during pregnancy has not shown any positive evidence of adverse effects on the fetus. There are, however, no adequate or well-controlled studies in pregnant women showing conclusively that harmful effects of these drugs on the fetus can be excluded. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_f8e0efcf-a28f-44b4-b440-e51cc0c5bc37"></a><a name="section-7.7"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Penicillins are excreted in breast milk. Caution should be exercised when penicillins are administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_42b99e3b-cd0c-44a2-b9fc-93735de15671"></a><a name="section-7.8"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Because of incompletely developed renal function in newborns, penicillinase-resistant penicillins (especially methicillin) may not be completely excreted, with abnormally high blood levels resulting. Frequent monitoring of blood levels is advisable in this group, with dosage adjustments when necessary. All newborns treated with penicillins should be monitored closely for clinical and laboratory evidence of toxic or adverse effects (see <span class="Bold">DOSAGE AND ADMINISTRATION</span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_f607c9d1-8e96-4fb8-9049-b8b1196dd858"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_b301580f-7030-45f1-9792-d4c8cb4cbe92"></a><a name="section-8.1"></a><p></p>
<h2>Body as a Whole</h2>
<p class="First">The reported incidence of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> to penicillin ranges from 0.7% to 10% (see <span class="Bold">WARNINGS</span>). Sensitization is usually the result of treatment, but some individuals have had immediate reactions to penicillin when first treated. In such cases, it is thought that the patients may have had prior exposure to the drug via trace amounts present in milk and vaccines.</p>
<p>Two types of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> to penicillin are noted clinically, immediate and delayed.</p>
<p>Immediate reactions usually occur within 20 minutes of administration and range in severity from <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> to <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioneurotic edema</span>, <span class="product-label-link" type="condition" conceptid="437904" conceptname="Laryngeal spasm">laryngospasm</span>, <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">vascular collapse</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. Such immediate <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> are very rare (see <span class="Bold">WARNINGS</span>) and usually occur after parenteral therapy, but have occurred in patients receiving oral therapy. Another type of immediate reaction, an accelerated reaction, may occur between 20 minutes and 48 hours after administration and may include <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>. Although <span class="product-label-link" type="condition" conceptid="22350" conceptname="Edema of larynx">laryngeal edema</span>, <span class="product-label-link" type="condition" conceptid="437904" conceptname="Laryngeal spasm">laryngospasm</span> and <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> occasionally occur, fatality is uncommon.</p>
<p>Delayed <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> to penicillin therapy usually occur after 48 hours and sometimes as late as two to four weeks after initiation of therapy. Manifestations of this type of reaction include <span class="product-label-link" type="condition" conceptid="432522" conceptname="Transfusion reaction due to serum protein reaction">serum sickness</span>-like symptoms (i.e., <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">arthralgia</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>) and various <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rashes</span>. <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="138455" conceptname="Stomatitis">stomatitis</span>, black or hairy tongue and other symptoms of <span class="product-label-link" type="condition" conceptid="4318531" conceptname="Gastrointestinal irritation">gastrointestinal irritation</span> may occur, especially during oral penicillin therapy.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_55107eab-c55d-4279-a993-4a38830ec3d4"></a><a name="section-8.2"></a><p></p>
<h2>Nervous System Reactions</h2>
<p class="First">Neurotoxic reactions similar to those observed with penicillin G may occur with large intravenous doses of the penicillinase-resistant penicillins, especially with patients with <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_176ce49a-3b76-4b95-a996-b3ed944238bb"></a><a name="section-8.3"></a><p></p>
<h2>Urogenital Reactions</h2>
<p class="First">Renal tubular damage and interstitial <span class="product-label-link" type="condition" conceptid="193253" conceptname="Nephritis">nephritis</span> have been associated with the administration of methicillin sodium and, infrequently, with the administration of nafcillin and oxacillin. Manifestations of this reaction may include <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span>, <span class="product-label-link" type="condition" conceptid="75004" conceptname="Frank hematuria">hematuria</span>, <span class="product-label-link" type="condition" conceptid="75650" conceptname="Proteinuria">proteinuria</span> and <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>. Methicillin-induced <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">nephropathy</span> does not appear to be dose-related and is generally reversible upon prompt discontinuation of therapy.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_f8bc473f-c266-4e22-8e69-03f954d9b799"></a><a name="section-8.4"></a><p></p>
<h2>Metabolic Reactions</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="320073" conceptname="Neutropenia">neutropenia</span> and <span class="product-label-link" type="condition" conceptid="4145241" conceptname="Bone marrow depression">bone marrow depression</span> have been associated with the use of methicillin sodium and nafcillin. Hepatotoxicity, characterized by <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> associated with <span class="product-label-link" type="condition" conceptid="438878" conceptname="Liver function tests abnormal">abnormal liver function tests</span>, mainly elevated <span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span> levels, has been associated with the use of oxacillin.</p>
<a name="id_4aec7f31-7fd9-4ee8-9be5-12034c1effa8"></a><table border="1" width="339">
<caption><span>RECOMMENDED DOSAGES FOR DICLOXACILLIN IN MILD TO MODERATE AND SEVERE <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">INFECTIONS</span></span></caption>
<col width="23.3%">
<col width="19.5%">
<col width="15.9%">
<col width="22.1%">
<col width="19.2%">
<tfoot><tr><td colspan="5" align="left"><dl class="Footnote">
<dt><a name="footnote-1" href="#footnote-reference-1">*</a></dt>
<dd>Patients weighing less than 40 kg (88 lbs)</dd>
</dl></td></tr></tfoot>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="left" valign="middle">DRUG</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="middle">ADULTS</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="middle">CHILDREN</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="middle"></td>
<td class="Botrule Rrule" align="left" valign="middle">Mild to Moderate</td>
<td class="Botrule Rrule" align="left" valign="middle">Severe</td>
<td class="Botrule Rrule" align="left" valign="middle">Mild to Moderate</td>
<td class="Botrule Rrule" align="left" valign="middle">Severe</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="middle">Dicloxacillin</td>
<td class="Botrule Rrule" align="left" valign="middle">125 mg every</td>
<td class="Botrule Rrule" align="left" valign="middle">250 mg every</td>
<td class="Botrule Rrule" align="left" valign="middle">12.5 mg/kg/day<a name="footnote-reference-1" href="#footnote-1" class="Sup">*</a>
</td>
<td class="Botrule Rrule" align="left" valign="middle">25 mg/kg/day<a href="#footnote-1" class="Sup">*</a>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="middle"></td>
<td class="Botrule Rrule" align="left" valign="middle">6 hours</td>
<td class="Botrule Rrule" align="left" valign="middle">6 hours</td>
<td class="Botrule Rrule" align="left" valign="middle">in equally</td>
<td class="Botrule Rrule" align="left" valign="middle">in equally</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="middle"></td>
<td class="Botrule Rrule" align="left" valign="middle"></td>
<td class="Botrule Rrule" align="left" valign="middle"></td>
<td class="Botrule Rrule" align="left" valign="middle">divided doses</td>
<td class="Botrule Rrule" align="left" valign="middle">divided doses</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="middle"></td>
<td class="Rrule" align="left" valign="middle"></td>
<td class="Rrule" align="left" valign="middle"></td>
<td class="Rrule" align="left" valign="middle">every 6 hours</td>
<td class="Botrule Rrule" align="left" valign="middle">every 6 hours</td>
</tr>
</tbody>
</table>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_8e146885-286c-415b-970b-fbf7780fb78b"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Bacteriologic studies to determine the causative organisms and their sensitivity to the penicillinase-resistant penicillins should always be performed. Duration of therapy varies with the type and severity of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> as well as the overall condition of the patient, therefore it should be determined by the clinical and bacteriological response of the patient. In severe <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infections</span>, therapy with penicillinase-resistant penicillins should be continued for at least 14 days. Therapy should be continued for at least 48 hours after the patient has become afebrile, asymptomatic and cultures are negative. The treatment of <span class="product-label-link" type="condition" conceptid="441589" conceptname="Endocarditis">endocarditis</span> and <span class="product-label-link" type="condition" conceptid="141663" conceptname="Osteomyelitis">osteomyelitis</span> may require a longer term of therapy.</p>
<p>Concurrent administration of the penicillinase-resistant penicillins and probenecid increases and prolongs serum penicillin levels.</p>
<p>Probenecid decreases the apparent volume of distribution and slows the rate of excretion by competitively inhibiting renal tubular secretion of penicillin. Penicillin-probenecid therapy is generally limited to those <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> where very high serum levels of penicillin are necessary.</p>
<p>Oral preparations of the penicillinase-resistant penicillins should not be used as initial therapy in serious, life-threatening <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> (see <span class="Bold">PRECAUTIONS - General</span>). Oral therapy with the penicillinase-resistant penicillins may be used to follow up the previous use of a parenteral agent as soon as the clinical condition warrants. For intramuscular gluteal injections, care should be taken to avoid sciatic <span class="product-label-link" type="condition" conceptid="381732" conceptname="Nerve injury">nerve injury</span>. With intravenous administration, particularly in elderly patients, care should be taken because of the possibility of <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span>.</p>
<p>NB: <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">INFECTIONS</span> CAUSED BY GROUP A BETA-HEMOLYTIC STREPTOCOCCI SHOULD BE TREATED FOR AT LEAST 10 DAYS TO HELP PREVENT THE OCCURRENCE OF ACUTE <span class="product-label-link" type="condition" conceptid="442313" conceptname="Rheumatic fever">RHEUMATIC FEVER</span> OR ACUTE <span class="product-label-link" type="condition" conceptid="4263367" conceptname="Glomerulonephritis">GLOMERULONEPHRITIS</span>.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_1cabede4-cf61-4157-8a7e-a9d0d1e88f38"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Dicloxacillin sodium capsules USP are available as follows:</p>
<p><span class="Bold">250 mg: </span>Each capsule contains dicloxacillin sodium monohydrate equivalent to 250 mg dicloxacillin, with green colored cap and light green colored body, imprinted "TEVA" on the cap and â€œ3123â€? on the body, available in bottles of 100.</p>
<p><span class="Bold">500 mg: </span>Each capsule contains dicloxacillin sodium monohydrate equivalent to 500 mg dicloxacillin, with green colored cap and light green colored body, imprinted "TEVA" on the cap and â€œ3125â€? on the body, available in bottles of 100.</p>
<p>Store at 20Â° to 25Â°C (68Â° to 77Â°F) [See USP Controlled Room Temperature].</p>
<p>Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).</p>
<p>References Available Upon Request.</p>
<p>Manufactured In Canada By:</p>
<p><span class="Bold">TEVA CANADA LIMITED </span></p>
<p>Toronto, Canada M1B 2K9</p>
<p>Manufactured For:</p>
<p><span class="Bold">TEVA PHARMACEUTICALS USA</span></p>
<p>Sellersville, PA 18960</p>
<p>Rev. F 8/2012</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_fe575b8b-ad9c-47b5-9562-5b20af91d6c1"></a><a name="section-11"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<div class="Figure"><img alt="43063473 Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=24e821aa-85b8-4f5a-aa13-83ff132952ca&amp;name=43063473.jpg"></div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_0355b8ee-1bed-4ed4-9b1e-cac5580e2bb3"></a><a name="section-11.1"></a><p></p>
<h2>Dicloxacillin Sodium Capsules USP 500 mg 100s Label Text</h2>
<p class="First"><span class="Bold">NDC </span>0093-<span class="Bold">3125</span>-01</p>
<p><span class="Bold">DICLOXACILLIN<br>SODIUM<br>Capsules USP<br>500 mg*</span></p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold">100 CAPSULES</span></p>
<p><span class="Bold">TEVA</span></p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DICLOXACILLIN SODIUMÂ 		
					</strong><br><span class="contentTableReg">dicloxacillin sodium capsule</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:43063-473(NDC:0093-3125)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DICLOXACILLIN SODIUM</strong> (DICLOXACILLIN) </td>
<td class="formItem">DICLOXACILLIN</td>
<td class="formItem">500Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>D&amp;C YELLOW NO. 10</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALUMINUM OXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C BLUE NO. 1</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>FD&amp;C BLUE NO. 2</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C RED NO. 40</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GELATIN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SHELLAC</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SORBITAN MONOLAURATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>FERROSOFERRIC OXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">GREEN (light green) ,Â GREEN</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE</td>
<td class="formLabel">Size</td>
<td class="formItem">22mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">TEVA;3125</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:43063-473-20</td>
<td class="formItem">20  in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA062286</td>
<td class="formItem">09/30/1990</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>PD-Rx Pharmaceuticals, Inc.
							(156893695)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>PD-Rx Pharmaceuticals, Inc. (156893695)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">PD-Rx Pharmaceuticals, Inc.</td>
<td class="formItem"></td>
<td class="formItem">156893695</td>
<td class="formItem">repack(43063-473)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>5b624e87-0cef-4f53-ad53-ab3dfb8c4293</div>
<div>Set id: 24e821aa-85b8-4f5a-aa13-83ff132952ca</div>
<div>Version: 4</div>
<div>Effective Time: 20121206</div>
</div>
</div>Â <div class="DistributorName">PD-Rx Pharmaceuticals, Inc.</div></p>
</body></html>
